BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang W, Li Y, Zou P, Wu M, Zhang Z, Zhang T. The Effects of Pharmaceutical Excipients on Gastrointestinal Tract Metabolic Enzymes and Transporters-an Update. AAPS J 2016;18:830-43. [PMID: 27184579 DOI: 10.1208/s12248-016-9928-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Park H, Ha ES, Kim MS. Current Status of Supersaturable Self-Emulsifying Drug Delivery Systems. Pharmaceutics 2020;12:E365. [PMID: 32316199 DOI: 10.3390/pharmaceutics12040365] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
2 Metry M, Krug SA, Karra VK, Ekins S, Hoag SW, Kane MA, Fink JC, Polli JE. Lack of an Effect of Polysorbate 80 on Intestinal Drug Permeability in Humans. Pharm Res. [DOI: 10.1007/s11095-022-03312-z] [Reference Citation Analysis]
3 Porat D, Dahan A. Active intestinal drug absorption and the solubility-permeability interplay. Int J Pharm 2018;537:84-93. [PMID: 29102702 DOI: 10.1016/j.ijpharm.2017.10.058] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
4 Dahlgren D, Sjöblom M, Lennernäs H. Intestinal absorption-modifying excipients: A current update on preclinical in vivo evaluations. European Journal of Pharmaceutics and Biopharmaceutics 2019;142:411-20. [DOI: 10.1016/j.ejpb.2019.07.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
5 Mundada VP, Patel MH, Mundada PK, Sawant KK. Development of Self-Microemulsifying Drug Delivery System to Improve Nisoldipine Bioavailability: Cell Line and In Vivo Evaluations : Development of Self-Microemulsifying Drug Delivery System. AAPS PharmSciTech 2021;22:256. [PMID: 34676456 DOI: 10.1208/s12249-021-02109-4] [Reference Citation Analysis]
6 Ruiz-Picazo A, Lozoya-Agullo I, González-Álvarez I, Bermejo M, González-Álvarez M. Effect of excipients on oral absorption process according to the different gastrointestinal segments. Expert Opin Drug Deliv 2021;18:1005-24. [PMID: 32842776 DOI: 10.1080/17425247.2020.1813108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Izgelov D, Freidman M, Hoffman A. Investigation of cannabidiol gastro retentive tablets based on regional absorption of cannabinoids in rats. Eur J Pharm Biopharm 2020;152:229-35. [PMID: 32422168 DOI: 10.1016/j.ejpb.2020.05.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Metry M, Polli JE. Evaluation of Excipient Risk in BCS Class I and III Biowaivers. AAPS J 2022;24:20. [PMID: 34988701 DOI: 10.1208/s12248-021-00670-1] [Reference Citation Analysis]
9 Sjöstedt N, Deng F, Rauvala O, Tepponen T, Kidron H. Interaction of Food Additives with Intestinal Efflux Transporters. Mol Pharmaceutics 2017;14:3824-33. [DOI: 10.1021/acs.molpharmaceut.7b00563] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
10 Butler J, Augustijns P. An Assessment of Occasional Bio-Inequivalence for BCS1 and BCS3 Drugs: What are the Underlying Reasons? J Pharm Sci 2021:S0022-3549(21)00399-3. [PMID: 34363838 DOI: 10.1016/j.xphs.2021.08.001] [Reference Citation Analysis]
11 Dong D, Quan E, Yuan X, Xie Q, Li Z, Wu B. Sodium Oleate-Based Nanoemulsion Enhances Oral Absorption of Chrysin through Inhibition of UGT-Mediated Metabolism. Mol Pharmaceutics 2017;14:2864-74. [DOI: 10.1021/acs.molpharmaceut.6b00851] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
12 Hofsäss MA, Dressman JB. The Discriminatory Power of the BCS-Based Biowaiver: A Retrospective With Focus on Essential Medicines. Journal of Pharmaceutical Sciences 2019;108:2824-37. [DOI: 10.1016/j.xphs.2019.04.030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
13 Martinez MN, Sinko B, Wu F, Flanagan T, Borbás E, Tsakalozou E, Giacomini KM. A Critical Overview of the Biological Effects of Excipients (Part I): Impact on Gastrointestinal Absorption. AAPS J 2022;24. [DOI: 10.1208/s12248-022-00711-3] [Reference Citation Analysis]
14 Gurjar R, Chan CYS, Curley P, Sharp J, Chiong J, Rannard S, Siccardi M, Owen A. Inhibitory Effects of Commonly Used Excipients on P-Glycoprotein in Vitro. Mol Pharm 2018;15:4835-42. [PMID: 30350641 DOI: 10.1021/acs.molpharmaceut.8b00482] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
15 Liu Q, Yang X, Sun J, Yu F, Zhang H, Gao J, Zheng A. Size-Dependent Biological Effects of Quercetin Nanocrystals. Molecules 2019;24:E1438. [PMID: 30979064 DOI: 10.3390/molecules24071438] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
16 Wen C, Hu H, Zhang W, Liu X, Jiang X, Wang L. Assessing CYP2C8-Mediated Pharmaceutical Excipient-Drug Interaction Potential: A Case Study of Tween 80 and Cremophor EL-35. Pharmaceutics 2021;13:1492. [PMID: 34575568 DOI: 10.3390/pharmaceutics13091492] [Reference Citation Analysis]
17 Zhu Q, Chen Z, Paul PK, Lu Y, Wu W, Qi J. Oral delivery of proteins and peptides: Challenges, status quo and future perspectives. Acta Pharm Sin B 2021;11:2416-48. [PMID: 34522593 DOI: 10.1016/j.apsb.2021.04.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
18 Gu YZ, Chu X, Houle R, Vlasakova K, Koeplinger KA, Bourgeois I, Palyada K, Anderson KD, Brynczka C, Bhatt B, Chen F, Smith R, Amin R, Glaab WE, Lebron J, Cox K, Sistare FD. Polyethlyene Glycol 200 can Protect Rats against Drug-Induced Kidney Toxicity through Inhibition of the Renal Organic Anion Transporter 3. Toxicol Sci 2019:kfz186. [PMID: 31406999 DOI: 10.1093/toxsci/kfz186] [Reference Citation Analysis]
19 Tikkanen A, Pierrot E, Deng F, Sánchez VB, Hagström M, Koenderink JB, Kidron H. Food Additives as Inhibitors of Intestinal Drug Transporter OATP2B1. Mol Pharm 2020;17:3748-58. [PMID: 32845645 DOI: 10.1021/acs.molpharmaceut.0c00507] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Parikh A, Kathawala K, Tan CC, Garg S, Zhou XF. Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro/in vivo evaluation. Drug Deliv 2017;24:962-78. [PMID: 28633547 DOI: 10.1080/10717544.2017.1337825] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
21 Reker D, Blum SM, Steiger C, Anger KE, Sommer JM, Fanikos J, Traverso G. "Inactive" ingredients in oral medications. Sci Transl Med 2019;11:eaau6753. [PMID: 30867323 DOI: 10.1126/scitranslmed.aau6753] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 13.5] [Reference Citation Analysis]
22 Dhritlahre RK, Ruchika, Padwad Y, Saneja A. Self-emulsifying formulations to augment therapeutic efficacy of nutraceuticals: From concepts to clinic. Trends in Food Science & Technology 2021;115:347-65. [DOI: 10.1016/j.tifs.2021.06.046] [Reference Citation Analysis]
23 Vasconcelos T, Marques S, Sarmento B. The biopharmaceutical classification system of excipients. Therapeutic Delivery 2017;8:65-78. [DOI: 10.4155/tde-2016-0067] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
24 Choudhury H, Maheshwari R, Pandey M, Tekade M, Gorain B, Tekade RK. Advanced nanoscale carrier-based approaches to overcome biopharmaceutical issues associated with anticancer drug ‘Etoposide’. Materials Science and Engineering: C 2020;106:110275. [DOI: 10.1016/j.msec.2019.110275] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
25 Patel R, Barker J, ElShaer A. Pharmaceutical Excipients and Drug Metabolism: A Mini-Review. Int J Mol Sci 2020;21:E8224. [PMID: 33153099 DOI: 10.3390/ijms21218224] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Lavan M, Knipp G. Considerations for Determining Direct Versus Indirect Functional Effects of Solubilizing Excipients on Drug Transporters for Enhancing Bioavailability. J Pharm Sci 2020;109:1833-45. [PMID: 32142715 DOI: 10.1016/j.xphs.2020.02.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Mai Y, Ashiru-oredope DA, Yao Z, Dou L, Madla CM, Taherali F, Murdan S, Basit AW. Boosting drug bioavailability in men but not women through the action of an excipient. International Journal of Pharmaceutics 2020;587:119678. [DOI: 10.1016/j.ijpharm.2020.119678] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
28 Babadi D, Dadashzadeh S, Osouli M, Daryabari MS, Haeri A. Nanoformulation strategies for improving intestinal permeability of drugs: A more precise look at permeability assessment methods and pharmacokinetic properties changes. J Control Release 2020;321:669-709. [PMID: 32112856 DOI: 10.1016/j.jconrel.2020.02.041] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
29 Cao S, Zhang M, Yuan M, Yang D, Zhao M, Zhang S, Wang P, Zhang R, Gao X. The pharmaceutical excipient PEG400 affect the absorption of baicalein in Caco-2 monolayer model by interacting with UDP-glucuronosyltransferases and efflux transport proteins. Pharmacol Res Perspect 2022;10:e00928. [PMID: 35148019 DOI: 10.1002/prp2.928] [Reference Citation Analysis]
30 Flanagan T. Potential for pharmaceutical excipients to impact absorption: A mechanistic review for BCS Class 1 and 3 drugs. Eur J Pharm Biopharm 2019;141:130-8. [PMID: 31128247 DOI: 10.1016/j.ejpb.2019.05.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]